Intellia Therapeutics
Brand in Healthcare · Global · Unclaimed Profile
About Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Intellia Therapeutics is a brand operating in the healthcare and health technology sector, encompassing medical services, telehealth, health IT, and patient care solutions. With a global focus, Intellia Therapeutics serves clients and partners across multiple regions and markets.
As a brand in the healthcare space, Intellia Therapeutics is positioned to work with companies looking for Telehealth services, Electronic health records, Patient engagement and related capabilities. Once this profile is claimed by a company representative, businesses will be able to request meetings through MeetBridge.
Company Details
| Company Name | Intellia Therapeutics |
|---|---|
| Business Type | Brand |
| Industry | Healthcare |
| Service Area | Global |
| Profile Status | Unclaimed — Sourced from public data |
| Website | http://intelliatx.com/ |
Healthcare Services and Capabilities
Companies like Intellia Therapeutics in the healthcare industry typically provide the following types of services:
- Telehealth services
- Electronic health records
- Patient engagement
- Clinical trial management
- Healthcare analytics
- Medical billing
- Compliance and HIPAA
- Remote patient monitoring
- Health IT consulting
- Population health management
The specific services offered by Intellia Therapeutics may vary. Claim this profile to add your specific services and start connecting with B2B partners.
Is this your company?
This profile for Intellia Therapeutics was created from publicly available information and hasn't been claimed yet. If you represent Intellia Therapeutics, claiming this profile allows you to:
- Manage and update your company information
- Receive and respond to B2B meeting requests
- Connect with relevant partners matched by industry and intent
- Access a free 90-day trial with full platform features
Frequently Asked Questions about Intellia Therapeutics
What does Intellia Therapeutics do?
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
How can I connect with Intellia Therapeutics for a partnership?
Intellia Therapeutics's profile on MeetBridge has not yet been claimed. Once a representative claims this profile, you'll be able to request B2B meetings directly through the platform.
What markets does Intellia Therapeutics serve?
Intellia Therapeutics focuses on worldwide, serving clients and partners across multiple continents and markets. Through MeetBridge, Intellia Therapeutics can connect with B2B partners both within their primary market and internationally.
What types of companies does Intellia Therapeutics work with?
As a brand in the Healthcare industry, Intellia Therapeutics typically works with affiliates, publishers, performance marketers, and channel partners. Through MeetBridge, Intellia Therapeutics can be matched with the most relevant partners.
What industry does Intellia Therapeutics operate in?
Intellia Therapeutics operates in the healthcare and health technology sector, encompassing medical services, telehealth, health IT, and patient care solutions. This sector includes capabilities such as telehealth services, electronic health records, patient engagement, clinical trial management, and more.
Is it free to contact Intellia Therapeutics on MeetBridge?
MeetBridge offers a free 90-day trial with 500 monthly points. Requesting a meeting costs points based on your plan. During the trial, you can contact Intellia Therapeutics and other companies at no charge. After the trial, a free plan or a Pro plan at $100/month keeps you connected to the network.
How should I prepare for a meeting with Intellia Therapeutics?
Before meeting with Intellia Therapeutics on MeetBridge, review their company profile and declared business intentions. Come prepared to explain your own role in the Healthcare space, what you're looking to achieve from the partnership, and why Intellia Therapeutics is a good fit for your goals. Meetings are 30 minutes — keep your introduction brief and focus on mutual value.
What makes Intellia Therapeutics stand out in the Healthcare industry?
Intellia Therapeutics is a brand with a clear focus on electronic health records across global markets. It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system. Companies looking for a reliable healthcare partner can explore a connection through MeetBridge.
Who should request a meeting with Intellia Therapeutics?
Companies looking to partner with a brand in the Healthcare industry are the most likely good fit for Intellia Therapeutics. If you operate in a complementary space and see potential for collaboration, a 30-minute discovery call on MeetBridge is the first step.
Similar Healthcare Companies on MeetBridge
Explore other healthcare companies in the MeetBridge directory that may be relevant for B2B partnerships:
- CytRx — Brand, Global
- Broadmoor Hospital — Brand, Global
- Averion, Inc. — Brand, North America
- Verona Pharma — Brand, Global
- Catholic Health Initiatives — Network, Global
- Hospital Universitario Insular de Gran Canaria — Brand, Global
- Hôpital Saint-Charles — Brand, Global
- HealthONE Colorado — Brand, Global
How MeetBridge Works
MeetBridge is a B2B meeting marketplace that helps companies discover and connect with relevant business partners through qualified 30-minute video meetings.
- Create your company profile — Sign up for free, describe your business, industry, and what you're looking for in B2B partnerships.
- Discover and match with partners — Our matching system scores companies by industry, geography, and mutual intent so you find the right fit fast.
- Book a 30-minute video meeting — Pick an available time slot, explain why it's a good fit, and connect via built-in video call — no external tools needed.
MeetBridge offers a free 90-day trial with 500 points per month. After the trial, companies can continue with a free plan or upgrade to Pro ($100/month) for expanded access.